
Last quarter Manulife delivered the kind of report that changes a narrative. Core EPS growth jumped to 16%, Hong Kong sales surged, Asia posted record earnings, and its Global Wealth and Asset Management arm finally stopped bleeding money after three straight quarters of outflows. Yet the stock has gone essentially nowhere since, and the Street is penciling in a quarter that looks flat. That gap between operating momentum and muted expectations is what makes the third-quarter report, due after the close on November 4, worth close attention.
Consensus calls for earnings of $0.83 per share, a touch above last quarter's $0.79 but about 1% below the $0.84 earned a year ago. The revenue estimate of $7.92 billion implies a 39% year-over-year decline. For a life insurer reporting under current accounting rules, headline revenue swings heavily with investment marks and says little about underlying profitability. The more telling point is that a flat EPS forecast sits well below the double-digit core EPS growth management just reported. Management offered no formal raise last quarter, only a reaffirmation of its 2027 targets, so the Street appears to be leaving room for the soft spots rather than extrapolating the rebound.
The first test is whether the growth engines keep running. Hong Kong annualized premium sales rose 37% last quarter, nearly double the first-quarter pace, and new business CSM grew 16%, which matters because that stored profit becomes future earnings. Continued double-digit sales growth across segments, and another year of CSM expansion near 20%, would confirm that the acceleration was not a one-quarter burst. The wealth business faces a similar proof point. A modest $0.4 billion inflow is a turnaround, not a trend. A second positive quarter, alongside a core EBITDA margin holding above 31%, would suggest the franchise has genuinely stabilized; a slide back into outflows would revive doubts.
The risks management flagged are where the quarter could disappoint. Canada core earnings fell 10% on elevated group disability claims, worse than the 6% decline in the first quarter. Management expects Canadian experience to drift toward neutral by year-end, so this report should show at least directional improvement. Another step down would undercut that assurance. China's tax scrutiny of offshore policies is newer and harder to measure. Mainland visitors account for roughly a quarter of Hong Kong sales, and while management does not expect that business to vanish, any visible slowdown in that channel would hit the most important growth story directly. Corporate segment losses drifting toward the top of the $300 million to $400 million range, falling U.S. investment spreads, and roughly C$30 million a year of forgone earnings from the Munich Re long-term care deal are smaller drags that together explain some of the Street's caution.
Sentiment has cooled noticeably, with bullish readings dropping to about 41% from 59% ahead of the prior report. The stock's 0.8% slip since then roughly matches the broader market, so investors have neither rewarded the strong quarter nor punished the new risks. Technically, shares at $44.65 sit comfortably above the 200-day moving average near $39.81 and within about 2% of the post-earnings high of $45.68, meaning a convincing report could push the stock through that ceiling.
The central question is whether Asia and wealth strength can keep outpacing Canada's claims problem and the China overhang. If Hong Kong sales hold up despite tax scrutiny and Canadian claims begin to normalize, the flat consensus looks conservative and the reacceleration story stays intact. If both risks worsen at once, last quarter may come to look like a peak rather than a turning point.
This earnings preview was originally published on Earnings Whispers.
This article is for informational purposes only and is not investment advice. Earnings Whispers and its staff may hold positions in the securities mentioned. It is AI-assisted, based on proprietary Earnings Whispers data and company reports, and edited by Earnings Whispers staff.
| Oct-27 | |
| Oct-27 | |
| Oct-22 | |
| Oct-21 | |
| Oct-13 | |
| Oct-08 | |
| Oct-05 | |
| Oct-01 | |
| Sep-21 | |
| Sep-10 | |
| Sep-01 | |
| Aug-31 | |
| Aug-10 | |
| Aug-06 | |
| Aug-05 |
Join thousands of traders who make more informed decisions with our premium features. Real-time quotes, advanced visualizations, alerts, and much more.
Learn more about Finviz Elite